Li, Jianxiong
Liang, Huaguo
Xiao, Wentao
Wei, Peng
Chen, Hongmei
Chen, Zexin
Yang, Ruihui
Jiang, Huan
Zhang, Yongli
Funding for this research was provided by:
Medical and Health Technology Project of Shenzhen Longgang District (LGKCYLWS2021000023, LGKCYLWS2021000023, LGKCYLWS2021000023, LGKCYLWS2021000023)
the “ovarian cancer chromosome instability region molecular marker target and clinical application research” enterprise horizontal project
National Natural Science Foundation of China (81102753)
Article History
Received: 11 January 2023
Accepted: 30 March 2023
First Online: 6 April 2023
Declarations
:
: Not applicable.
: Not applicable.
: The authors declare that they have no competing interests.